Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10195 | 1083 | 34.2 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
2637 | 2 | IVABRADINE//SINOATRIAL NODE//HCN CHANNELS | 3514 |
10195 | 1 | IVABRADINE//RESTING HEART RATE//HOWARD GILMAN HEART VALVE DIS | 1083 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | IVABRADINE | authKW | 4827723 | 22% | 71% | 242 |
2 | RESTING HEART RATE | authKW | 852807 | 5% | 55% | 55 |
3 | HOWARD GILMAN HEART VALVE DIS | address | 476454 | 2% | 65% | 26 |
4 | HEART RATE | authKW | 465761 | 37% | 4% | 396 |
5 | HEART RATE REDUCTION | authKW | 352405 | 2% | 63% | 20 |
6 | I F CHANNEL | authKW | 225549 | 1% | 100% | 8 |
7 | ETTORE SANSAVINI HLTH SCI FDN | address | 192213 | 1% | 45% | 15 |
8 | I F INHIBITION | authKW | 144994 | 1% | 86% | 6 |
9 | I F CURRENT | authKW | 144152 | 1% | 34% | 15 |
10 | S 16257 | authKW | 117472 | 0% | 83% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 22216 | 56% | 0% | 605 |
2 | Peripheral Vascular Diseases | 2730 | 15% | 0% | 165 |
3 | Pharmacology & Pharmacy | 431 | 14% | 0% | 151 |
4 | Medicine, General & Internal | 306 | 9% | 0% | 101 |
5 | Medicine, Research & Experimental | 28 | 3% | 0% | 34 |
6 | Geriatrics & Gerontology | 20 | 1% | 0% | 11 |
7 | Public, Environmental & Occupational Health | 18 | 3% | 0% | 34 |
8 | Gerontology | 10 | 1% | 0% | 6 |
9 | Endocrinology & Metabolism | 5 | 2% | 0% | 24 |
10 | Physiology | 4 | 2% | 0% | 19 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HOWARD GILMAN HEART VALVE DIS | 476454 | 2% | 65% | 26 |
2 | ETTORE SANSAVINI HLTH SCI FDN | 192213 | 1% | 45% | 15 |
3 | IAVONE CARDIOVASC TRANSLAT | 112766 | 1% | 50% | 8 |
4 | LA PITIE SALPETRIERE HOSP | 82934 | 1% | 18% | 16 |
5 | GVM CARE | 78974 | 2% | 11% | 25 |
6 | ROBERTSON BIOSTAT | 74373 | 4% | 6% | 42 |
7 | KLIN INNERE MED KARDIOL ANGIOL INTERNIST INTENSIV | 63434 | 0% | 75% | 3 |
8 | ES HLTH SCI FDN | 57522 | 1% | 20% | 10 |
9 | RONALD JOAN IAVONE CARDIOVASC TRANSLAT I | 56387 | 0% | 100% | 2 |
10 | NHLI IMPERIAL | 51542 | 1% | 23% | 8 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN HEART JOURNAL SUPPLEMENTS | 63220 | 4% | 5% | 48 |
2 | CLINICAL RESEARCH IN CARDIOLOGY | 14636 | 2% | 2% | 24 |
3 | ADVANCES IN CARDIOLOGY | 13253 | 1% | 6% | 8 |
4 | CARDIOVASCULAR THERAPY AND PREVENTION | 10904 | 2% | 2% | 17 |
5 | KARDIOLOGIYA | 7932 | 4% | 1% | 43 |
6 | EUROPEAN HEART JOURNAL | 6386 | 4% | 0% | 48 |
7 | AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS | 4270 | 1% | 2% | 8 |
8 | EUROPEAN JOURNAL OF HEART FAILURE | 3847 | 2% | 1% | 18 |
9 | EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2158 | 1% | 1% | 8 |
10 | ADVANCES IN THERAPY | 2085 | 1% | 1% | 11 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IVABRADINE | 4827723 | 22% | 71% | 242 | Search IVABRADINE | Search IVABRADINE |
2 | RESTING HEART RATE | 852807 | 5% | 55% | 55 | Search RESTING+HEART+RATE | Search RESTING+HEART+RATE |
3 | HEART RATE | 465761 | 37% | 4% | 396 | Search HEART+RATE | Search HEART+RATE |
4 | HEART RATE REDUCTION | 352405 | 2% | 63% | 20 | Search HEART+RATE+REDUCTION | Search HEART+RATE+REDUCTION |
5 | I F CHANNEL | 225549 | 1% | 100% | 8 | Search I+F+CHANNEL | Search I+F+CHANNEL |
6 | I F INHIBITION | 144994 | 1% | 86% | 6 | Search I+F+INHIBITION | Search I+F+INHIBITION |
7 | I F CURRENT | 144152 | 1% | 34% | 15 | Search I+F+CURRENT | Search I+F+CURRENT |
8 | S 16257 | 117472 | 0% | 83% | 5 | Search S+16257 | Search S+16257 |
9 | IF INHIBITOR | 112774 | 0% | 100% | 4 | Search IF+INHIBITOR | Search IF+INHIBITOR |
10 | IVABRADIN | 90218 | 0% | 80% | 4 | Search IVABRADIN | Search IVABRADIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BOHM, M , REIL, JC , DEEDWANIA, P , KIM, JB , BORER, JS , (2015) RESTING HEART RATE: RISK INDICATOR AND EMERGING RISK FACTOR IN CARDIOVASCULAR DISEASE.AMERICAN JOURNAL OF MEDICINE. VOL. 128. ISSUE 3. P. 219 -228 | 73 | 62% | 23 |
2 | NAWARSKAS, JJ , BOWMAN, BN , ANDERSON, JR , (2015) IVABRADINE: A UNIQUE AND INTRIGUING MEDICATION FOR TREATING CARDIOVASCULAR DISEASE.CARDIOLOGY IN REVIEW. VOL. 23. ISSUE 4. P. 201 -211 | 62 | 85% | 2 |
3 | PALATINI, P , ROSEI, EA , CASIGLIA, E , CHALMERS, J , FERRARI, R , GRASSI, G , INOUE, T , JELAKOVIC, B , JENSEN, MT , JULIUS, S , ET AL (2016) MANAGEMENT OF THE HYPERTENSIVE PATIENT WITH ELEVATED HEART RATE: STATEMENT OF THE SECOND CONSENSUS CONFERENCE ENDORSED BY THE EUROPEAN SOCIETY OF HYPERTENSION.JOURNAL OF HYPERTENSION. VOL. 34. ISSUE 5. P. 813 -821 | 55 | 76% | 3 |
4 | DEEDWANIA, P , (2013) SELECTIVE AND SPECIFIC INHIBITION OF I (F) WITH IVABRADINE FOR THE TREATMENT OF CORONARY ARTERY DISEASE OR HEART FAILURE.DRUGS. VOL. 73. ISSUE 14. P. 1569-1586 | 58 | 83% | 10 |
5 | CUSTODIS, F , REIL, JC , SCHIRMER, SH , ADAM, O , MOHLENKAMP, S , LAUFS, U , BOHM, M , (2014) HEART RATE: CLINICAL VARIABLE AND RISK MARKER.DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. VOL. 139. ISSUE 33. P. 1661 -1672 | 57 | 84% | 0 |
6 | SCICCHITANO, P , CORTESE, F , RICCI, G , CARBONARA, S , MONCELLI, M , IACOVIELLO, M , CECERE, A , GESUALDO, M , ZITO, A , CALDAROLA, P , ET AL (2014) IVABRADINE, CORONARY ARTERY DISEASE, AND HEART FAILURE: BEYOND RHYTHM CONTROL.DRUG DESIGN DEVELOPMENT AND THERAPY. VOL. 8. ISSUE . P. 689 -700 | 59 | 74% | 10 |
7 | GUGLIN, M , (2013) HEART RATE REDUCTION IN HEART FAILURE: IVABRADINE OR BETA BLOCKERS?.HEART FAILURE REVIEWS. VOL. 18. ISSUE 4. P. 517 -528 | 58 | 79% | 1 |
8 | ZHANG, DF , SHEN, XL , QI, X , (2016) RESTING HEART RATE AND ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN THE GENERAL POPULATION: A META-ANALYSIS.CANADIAN MEDICAL ASSOCIATION JOURNAL. VOL. 188. ISSUE 3. P. E53 -E63 | 47 | 67% | 5 |
9 | ZHANG, DF , WANG, WJ , LI, F , (2016) ASSOCIATION BETWEEN RESTING HEART RATE AND CORONARY ARTERY DISEASE, STROKE, SUDDEN DEATH AND NONCARDIOVASCULAR DISEASES: A META-ANALYSIS.CANADIAN MEDICAL ASSOCIATION JOURNAL. VOL. 188. ISSUE 15. P. E384 -E392 | 46 | 81% | 0 |
10 | FERRARI, R , FOX, K , (2016) HEART RATE REDUCTION IN CORONARY ARTERY DISEASE AND HEART FAILURE.NATURE REVIEWS CARDIOLOGY. VOL. 13. ISSUE 8. P. 493 -+ | 57 | 58% | 1 |
Classes with closest relation at Level 1 |